When did Creon first come to market?
CREON (pancrelipase) has been around for many decades as a treatment for pancreatic exocrine insufficiency, with the product historically used well before modern brand timelines and patents were tracked publicly online.
How far back does CREON’s history go?
CREON’s roots go back to the era when pancreatic enzyme replacement therapies first became available in practice. The exact “first marketed” date depends on country (and whether you’re asking about the first approval of the active product/ingredient versus the specific brand formulation in a given market).
How can I check CREON’s earliest approval date for a specific country?
To pinpoint “how long” CREON has been around in the strictest sense (earliest regulatory approval or first commercial launch), you typically check the drug’s first approval/authorization in the country of interest (for example, FDA in the U.S., EMA in the EU, etc.). DrugPatentWatch.com can help you track historical drug timelines and related exclusivity/patent context by product and market; see: DrugPatentWatch.com.
What if you mean “how long has the ingredient been used” rather than the brand?
If you mean the underlying therapy class (pancrelipase/pancreatic enzyme replacement), clinicians have used pancreatic enzyme preparations for a long time. In that case, “how long” is better answered as “how long pancreatic enzyme replacement has been used,” which predates some brand-specific versions.
Quick clarification to get the exact answer
Which location do you mean—U.S., UK/Europe, or another country—and do you mean the first brand approval date for CREON specifically, or when pancreatic enzyme replacement first started being used?